TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HURA

TuHURA Biosciences Inc

Healthcare · Biotechnology

1.90$ -3.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow HURA
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – – – – – – – – – – –
– – +62.2% +47.0% -33.3% -38.8% +220.0% +1,089.7% -2.0% -52.5% -34.2% -38.9%
– – – – – – – – -66.7% +119.4% +309.0% +228.0%
– -122.3% – – +96.5% -57.1% -644.4% – – -68.8% +575.0% -195.8%
– -100.0% -75.0% +985,084,900.0% -100.0% -100.0% – -59.0% +1,006.0% +118.4% -26.9% +31.4%
– – +25.0% -39.6% – – – -100.3% +1,006.0% +3,474.9% +366.7% -77.9%
– +33.3% +0.0% +0.0% +0.0% -4.3% +0.0% +0.0% +0.0% -25.0% -100.0% –
– – – – – – – – – – -100.0% –
– – – – – – – – -219.0% – +964.0% -97.8%
– +1,028.3% -11.5% +9.2% -56.0% +62.0% +294.5% -72.9% +130.7% -83.6% +1,019.2% -33.1%
– – -90.3% -243.2% – – – -94.1% +1,721.8% -221.6% – -200.5%
– – – – – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?